CapEdge
Loading...
Advanced
What's new? Log in Free sign up
  • Home
  • Sectors & IndustriesSectors
  • Earnings
  • IPOs
  • SPACs
  • Transcripts
  • Insider
  • Institutional
  • Crypto
  • Screeners
  • Reddit
  • Splits
  • ZCMD Dashboard
  • Financials
  • Filings
  • Institutional
  • Shorts
  • News
  • Reddit

Zhongchao (ZCMD)

Company Profile
Incorporated in 2012 with headquarter offices in Shanghaiand Beijing, China, Zhongchao Inc. is an online provider of healthcare information, professional training and educational services to healthcare professionals under its 'MDMOOC' platform (www.mdmooc.org) and to the public under its 'Sunshine Health Forums' platform (www.ygjkclass.com) in China. The Company also offers patient management services under its 'Zhongxun' platform (www.zhongxun.online).
Zhongchao logo

Company profile

Ticker
ZCMD
Exchange
NASDAQ
Website
www.izcmd.com
CEO
Wei Guang Yang
Employees
Incorporated
Cayman Islands
Location
China
Fiscal year end
Dec 31
Sector
Educational Services > Elementary and Secondary Schools
Industry (SIC)
Services - Educational Services
Graham • Adtalem Global Education • New Oriental Education & Technology • Perdoceo Education • Zovio • Stride • Meta Data Limited • Sunlands Technology • 17 Education & Technology • Ambow Education Holding ...
SEC CIK
0001785566
Corporate docs
Articles of Incorporation & Bylaws
Underwriting Agreements
Indentures
Material Contracts & Credit Agreements
Subsidiaries Lists
Subsidiaries
Zhongchao Group Inc. • Zhongchao USA LLC • Zhongchao Group Limited • Beijing Zhongchao Zhongxing Technology Limited • Zhongchao Medical Technology (Shanghai) Corp. • Shanghai Maidemu Cultural Communication Corp. • Shanghai Huijing Information Technology Co., Ltd. • Beijing Zhongchao Boya Medical Technology Co., Ltd. • Zhixun Internet Hospital (Liaoning) Co., Ltd. • Hainan Zhongteng Medical Technology Co., Ltd. ...

ZCMD stock data

Latest filings (excl ownership)
View all
6-K
Report of Foreign Private Issuer
16 Dec 22
6-K
Zhongchao Inc. Establishes Chongqing Xinjiang Pharmaceutical Co., Ltd. to Improve Patient Access to Medications
28 Sep 22
6-K
Report of Foreign Private Issuer
27 Sep 22
6-K
Report of Foreign Private Issuer
28 Jul 22
6-K
Notice of Annual General Meeting of Shareholders
14 Jun 22
20-F
2021 FY
Annual report (foreign)
9 May 22
NT 20-F
Notice of late annual filing (foreign)
2 May 22
6-K
Report of Foreign Private Issuer
17 Dec 21
424B5
Prospectus supplement for primary offering
17 Dec 21
6-K
Report of Foreign Private Issuer
12 Nov 21
Latest ownership filings
SC 13D/A
Yang Weiguang
21 May 21
SC 13D
Beneficial ownership report
26 Feb 20

Financial summary

Financial statements Chart ZCMD financial data
Quarter (USD) Dec 21 Dec 20 Dec 19
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Annual (USD) Dec 21 Dec 20 Dec 19
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Financial data from Zhongchao earnings reports.

Institutional ownership, Q2 2022

ZCMD institutional ownership history Ownership history
13F holders Current Prev Q Change
Total holders 5 5 –
Opened positions 1 3 -66.7%
Closed positions 1 0 NEW
Increased positions 2 1 +100.0%
Reduced positions 0 0
13F shares Current Prev Q Change
Total value 197.95 mm 197.95 mm +0.0%
Total shares 82.49 mm 82.49 mm +0.0%
Total puts 0.00 0.00
Total calls 0.00 0.00
Total put/call ratio – – –
Largest owners Shares Value Change
Yang Weiguang 82.47 mm $197.92 mm 0.0%
Renaissance Technologies 16.50 k $21.00 k +5.8%
UBS UBS Group AG - Registered Shares 6.28 k $8.00 k +46.0%
Captrust Financial Advisors 696.00 $1.00 k NEW
Blue Bell Private Wealth Management 50.00 $0.00 0.0%
Proequities 0.00 $0.00
Largest transactions Shares Bought/sold Change
UBS UBS Group AG - Registered Shares 6.28 k +1.98 k +46.0%
MS Morgan Stanley 0.00 -1.61 k EXIT
Renaissance Technologies 16.50 k +900.00 +5.8%
Captrust Financial Advisors 696.00 +696.00 NEW
Proequities 0.00 0.00
Blue Bell Private Wealth Management 50.00 0.00 0.0%
Yang Weiguang 82.47 mm 0.00 0.0%
Data from 13F filings, for the last complete 13F reporting period. For most recent data, click the ownership history button. Values as filed, not updated for current price. Long positions only.

News

From Benzinga Pro
12 Consumer Discretionary Stocks Moving In Monday's After-Market Session
23 Jan 23
12 Consumer Discretionary Stocks Moving In Wednesday's After-Market Session
4 Jan 23
Zhongchao Inc. Announces Drug Distributorship In China Of Indian Generic Drugs Of Natco Pharma Limited
4 Jan 23
SHANGHAI, Jan. 4, 2023 /PRNewswire/ -- Zhongchao Inc. (NASDAQ:ZCMD) ("Zhongchao" or the "Company"), a platform-based internet technology company offering services to patients with oncology
Zhongchao Inc.'s China Operating Entity, Chongqing Xinjiang Pharmaceutical Co., Ltd. Obtained Pharmaceutical Trade and Medical Device Operation Licenses, Ready to Enter Into Pharmaceuticals Circulation Market
3 Nov 22

Press releases

From Benzinga Pro
Zhongchao Inc. Announces Introduction of Indian Anti-influenza Drugs to China
31 Jan 23
SHANGHAI, Jan. 31, 2023 /PRNewswire/ -- Zhongchao Inc. (NASDAQ:ZCMD) ("Zhongchao" or the "Company"), a platform-based internet technology company offering services to patients with oncology and other
Zhongchao Inc. Launches Medication Management Assistance Mini Program to Facilitate Cancer Treatment
19 Jan 23
SHANGHAI, Jan. 19, 2023 /PRNewswire/ -- Zhongchao Inc. (NASDAQ:ZCMD) ("Zhongchao" or the "Company"), a platform-based internet technology company offering services to patients with oncology and other
Zhongchao Inc. Announces Drug Distributorship in China of Indian Generic Drugs of Natco Pharma Limited
4 Jan 23
SHANGHAI, Jan. 4, 2023 /PRNewswire/ -- Zhongchao Inc. (NASDAQ:ZCMD) ("Zhongchao" or the "Company"), a platform-based internet technology company offering services to patients with oncology and other major
Zhongchao Inc. Established SID Liver Cancer Comprehensive-Disciplinary Physician Education Platform
5 Dec 22
Zhongchao Inc.'s China Operating Entity, Chongqing Xinjiang Pharmaceutical Co., Ltd. Obtained Pharmaceutical Trade and Medical Device Operation Licenses, Ready to Enter Into Pharmaceuticals Circulation Market
3 Nov 22
Finsight
Resources
  • Knowledgebase
  • Log In
  • Register
Company
  • About
  • Contact
  • Solutions
Products
  • Deal Roadshow
  • DealVDR
  • Evercall
  • Finsight.com
CapEdge
  • Earnings Calendar
  • Earnings Transcripts
  • EDGAR Filing Screener
  • IPO Calendar
  • Compliance
  • Privacy
  • Security
  • Terms
AngelList LinkedIn